US Must Reshore AI Drug Discovery Infrastructure | Kevin Weil
Warp Sciences co-founder and CEO Kevin Weil discusses emerging from stealth with $215 million to build AI-driven, automated chemistry labs in the US. He addresses the geopolitical urgency of reshoring drug discovery from China and explains why generating massive experimental data via robotic labs is essential to making AI models breakthroughs in hard sciences. Check out our sponsor Lovable: https://lovable.dev. Turn ideas into software people love.
MTS is a live news and interview show covering technology, business, politics, and culture as it happens.
Follow MTS:
X |…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.